The average age in the present cohort was 74 years (18-93 years), with 83 males and 21 females. The present cohort was consisted of 57 patients with benign prostatic hyperplasia (BPH), 15 patients with overactive bladder (OAB), 9 patients with neurogenic bladder (NB), 15 patients with BPH + OAB, 3 patients with BPH + NB, and 5 other cases. The psychological stress indexes evaluated by SRS- 18 and bodyweight have not significantly changed among before, during and after the declaration (SRS-18 total score:7.1±7.9、8.6±8.9、9.5±10.1, P = 0.20, and Body weight:62.1±11.2kg、63.6±11.2kg、62.9±10.9kg, P=0.67, respectively). In addition, the psychological stress indexes of each subscores were compared, but no significant differences were obserbed among each subscores (anxiety / depression: P=0.61, moody / anger: P=0.83, and lethargy: P=0.24, respectively). LUTS evaluated by IPSS and OABSS have not significantly changed before, during, after the declaration (IPSS: 12.7±7.3、13.4±7.0、13.0±7.2(P=0.82), and OABSS: 4.9±2.9、4.8±3.0、4.6±2.8(P=0.78), respectively). Post-voided residual urine volume has also not significantly changed (41.8±49.6ml、71.5±88.4ml、65.1±77.4ml ,P=0.24). However, the change ratio of IPSS voiding symptom subscore from before the declaration to during declaration significantly more worsened in the anxiety / depression stress aggravation (+) group than in the anxiety / depression stress aggravation (-) group (61.9 ±135.67%, 4.2 ±31.22%, respectively, P = 0.002, Figure 1). The change ratio of IPSS storage symptom subscore from before the declaration to during declaration also significantly more worsened in the moody / angry stress aggravation (+) group than in the in the moody / angry stress aggravation (-) group (38.8%± 73.4%, 7.3 ± 14.3%, respectively, P = 0.03, Figure 2). In addition, there were no significant differences in the ratio of OABSS change rate and residual urine volume between the aggravation (+) group and aggravation (-) group.